Bazaarvoice Inc (NASDAQ:BV)’s share price soared 0% or 0 to reach at $5.45 during previous trading session. A total of 1.02 Million shares exchanged hands, whereas the company’s average trading volume stands at 909.9 Million shares. Bazaarvoice Inc (NASDAQ:BV) has a market capitalization of $471.21 Million and most recently 86.46 Million outstanding shares have been calculated.

According to sentiments of 6 analysts the mean estimates of short term price target for the company’s stock is marked at $5.83. The most optimistic analyst sees the stock reaching $7 while the most conventional predicts the target price at $5.

In terms of Buy/Sell recommendations, 4 analysts have a consensus rating of 3 on the shares of Bazaarvoice Inc (NASDAQ:BV). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 5 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Bazaarvoice Inc (NASDAQ:BV)’s distance from 20 day simple moving average is 0.1237 along with distance from 50 day simple moving average of 4.86 whereas its distance from 200 day simple moving average is 4.79. Bazaarvoice Inc (NASDAQ:BV)’s price distance from 52-week high is -0.91 and from 52-week low is 43.42. The stock hit its 52-week high price on 12/05/17, and 52-week low price on 03/08/17. The stock’s 52-week price fluctuated within the range of $5.50 – $3.80.

Bazaarvoice Inc (NASDAQ:BV)’s shares climbed 0% in the past week and soared 17.2% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 12.95% while its year to date performance is at 12.37%.

While taking a glance at financials, we can look at a number of key indicators. Bazaarvoice Inc (NASDAQ:BV) has a Return on Assets (ROA) of -2.9. The company currently has a Return on Equity (ROE) of -4.8 and a Return on Investment (ROI) of -6.3. Average true range (ATR-14) of the company sets at 0.16, along with its weekly and monthly volatility of 1.20% and 3.05% respectively. Relative strength index (RSI-14) for Bazaarvoice Inc (NASDAQ:BV) is at 68.82. Beta value of the stock stands at 0.6.

The company’s price to free cash flow for trailing twelve months is 33.42. Its quick ratio for most recent quarter is 1.3 along with current ratio for most recent quarter of 1.3. Total debt to equity ratio of Bazaarvoice Inc (NASDAQ:BV) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Vistagen Therap. Com (NASDAQ:VTGN) soared 17.95% or 0.14 to reach at $0.92 during previous trading session. Vistagen Therap. Com (NASDAQ:VTGN) has a market capitalization of $11.53 Million and most recently 12.53 Million outstanding shares have been calculated. A total of 1.02 Million shares exchanged hands, whereas the company’s average trading volume stands at 181.57 Million shares.

According to 1 analysts Vistagen Therap. Com (NASDAQ:VTGN)’s price will reach at $30 during 52 weeks. Stock’s minimum price target estimates has been figured out at $30 while the maximum price target forecast is established at $30.

Shares of Vistagen Therap. Com (NASDAQ:VTGN) climbed 27.78% in the past week and soared 17.95% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -51.32% while its year to date performance is at -75.34%.

Vistagen Therap. Com (NASDAQ:VTGN)’s 52-week price fluctuated within the range of $4.08 – $0.69. Its price distance from 52-week high is -77.42 and from 52-week low is 33.33. The stock hit its 52-week high price on 12/14/16, and 52-week low price on 11/29/17. Vistagen Therap. Com (NASDAQ:VTGN)’s distance from 20 day simple moving average is0.1061 along with distance from 50 day simple moving average of 0.91 whereas its distance from 200 day simple moving average is 1.55.

Total debt to equity ratio of Vistagen Therap. Com (NASDAQ:VTGN) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 2.1 along with current ratio for most recent quarter of 2.1.

Average true range (ATR-14) of the company sets at 0.13, along with its weekly and monthly volatility of 20.09% and 13.74% respectively. Relative strength index (RSI-14) for Vistagen Therap. Com (NASDAQ:VTGN) is at 49.45. Beta value of the stock stands at -0.73. Vistagen Therap. Com (NASDAQ:VTGN) has a Return on Assets (ROA) of -244.1. The company currently has a Return on Equity (ROE) of -697.2 and a Return on Investment (ROI) of 0.